The European Food Safety Authority (EFSA) has taken a new step in the ongoing saga of food innovation and regulation by publicly issuing a scientific opinion that confirms the safety of a genetically modified enzyme used in food processing. This disclosure, dated 5 February 2026, shakes up the dynamics between biotech companies, food producers, regulators, and consumers by reassuring stakeholders that this novel ingredient poses no safety concerns under its intended use.
The information stems from a detailed scientific assessment published by EFSA, Europe's premier agency for food safety, based on rigorous testing and data analysis. The document titled “Safety evaluation of the food enzyme triacylglycerol lipase from the genetically modified Trichoderma reseei strain AR‐822” reflects the expert evaluation by EFSA's Panel on Food Contact Materials, Enzymes and Processing Aids.
Far from being legislative, this document is a scientific opinion that substantiates safety rather than introduces binding rules. It features concrete experimental data including genotoxicity tests, repeated dose toxicity studies in rats, and sequence homology analysis that underpin its conclusions. EFSA specifies measurable parameters such as the highest dose tested without adverse effects and the dietary exposure estimates for European populations.
EFSA's policy orientation highlights a cautious but positive regulatory approach to genetically modified microbial enzymes in food production; the agency acknowledges innovation benefits while maintaining stringent safety thresholds. This endorses the use of such modified enzymes in five food manufacturing processes but requires monitoring exposure levels to ensure consumer protection.
Stakeholders impacted include the biotech firm AB Enzymes GmbH producing the enzyme, food manufacturers applying it in processing, national food safety authorities overseeing regulatory compliance, and consumers whose safety and allergenic exposure are carefully considered. While providing an opportunity for market innovation and potentially improved food processing, the evaluation imposes a high standard of proof and ongoing risk assessment to avoid adverse effects.
This opinion represents a continuation of EFSA's science-based role in food safety assurance. Next steps involve monitoring by national authorities and industry, possible questions or requests for clarifications by the European Commission, and watchful observation by consumer groups for allergens and compliance. EFSA's stance provides a scientific foundation facilitating informed regulatory and commercial decisions rather than triggering immediate regulatory changes.
← Atlas › News